Soliris (eculizumab)
pCPA File Number:
21270
Negotiation Status:
Under consideration for negotiation
Indication(s):
Neuromyelitis optica spectrum disorder (NMOSD)
Sponsor/Manufacturer:
Alexion Pharma GMBH
CADTH Project Number:
SR0640-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable